Roche
Search results
1 day ago · At Lonza, we enable a healthier world by supporting our healthcare customers on the path to commercialization. Working across five continents, our global community of around 18,000 colleagues helps pharmaceutical, biotech and nutrition companies to bring their treatments to market.
Lonza is one of the world’s largest healthcare manufacturing organizations, helping pharmaceutical, biotech and nutrition companies to bring their treatments to market. United by our vision to bring any therapy to life, we support our customers with a combination of technological insight, world-class manufacturing, scientific expertise ...
Lonza Group AG is a Swiss multinational manufacturing company for the pharmaceutical, biotechnology and nutrition sectors, headquartered in Basel, with major facilities in Europe, North America and South Asia. Lonza was established under that name in the late 19th-century in Switzerland.
Overview of key investor relevant topics addressed by Lonza about its shares, general finance and investor relations services. Learn more Bond Investors and Credit Information
6 days ago · Divisional Overview. Biologics reported continued robust sales growth of 7.3% 1 compared to H1 2023, supported by sustained commercial demand. Excluding COVID-related mRNA sales in H1 2023, sales growth was in the mid-teens compared to the prior year.
About us. At Lonza, we enable A Healthier World by supporting our healthcare customers on the path to commercialization. Our community of 16,000 talented employees work across a global network of...
Dear Friends of Lonza, Welcome to our Sustainability Report 2021. This year was important for sustainability across our global network. We have redesigned our business to become a pure- play strategic partner to the healthcare industry, with a focus on the pharma, biotech and nutrition markets.
Lonza. Our redesigned performance and rewards structure – the Lonza Bonus – was launched in 2022. This aligns our divisions and functions into one performance structure, and is designed to recognize top talent with a consistent metric that takes Dear Stakeholders 125 years on from the foundation of our company, Lonza is
We provide life science researchers with the tools they need to develop and test therapeutics, from basic research to final product release. Lonza’s Bioscience products and services range from cell culture and discovery technologies for research, to quality control tests and software for biomanufacturing.
During the early years of the decade, Lonza created a research group to apply its existing expertise in fine chemistry and organic substances to the biotech field. The goal was both to look at customer needs and explore new areas.
